51
|
Abe K, Hayato Y, Iida T, Ikeda M, Iyogi K, Kameda J, Koshio Y, Kozuma Y, Miura M, Moriyama S, Nakahata M, Nakayama S, Obayashi Y, Sekiya H, Shiozawa M, Suzuki Y, Takeda A, Takenaga Y, Takeuchi Y, Ueno K, Ueshima K, Watanabe H, Yamada S, Yokozawa T, Ishihara C, Kaji H, Lee KP, Kajita T, Kaneyuki K, McLachlan T, Okumura K, Shimizu Y, Tanimoto N, Martens K, Vagins MR, Labarga L, Magro LM, Dufour F, Kearns E, Litos M, Raaf JL, Stone JL, Sulak LR, Goldhaber M, Bays K, Kropp WR, Mine S, Regis C, Smy MB, Sobel HW, Ganezer KS, Hill J, Keig WE, Jang JS, Kim JY, Lim IT, Albert JB, Scholberg K, Walter CW, Wendell R, Wongjirad TM, Tasaka S, Learned JG, Matsuno S, Hasegawa T, Ishida T, Ishii T, Kobayashi T, Nakadaira T, Nakamura K, Nishikawa K, Nishino H, Oyama Y, Sakashita K, Sekiguchi T, Tsukamoto T, Suzuki AT, Minamino A, Nakaya T, Fukuda Y, Itow Y, Mitsuka G, Tanaka T, Jung CK, Taylor I, Yanagisawa C, Ishino H, Kibayashi A, Mino S, Mori T, Sakuda M, Toyota H, Kuno Y, Kim SB, Yang BS, Ishizuka T, Okazawa H, Choi Y, Nishijima K, Koshiba M, Yokoyama M, Totsuka Y, Chen S, Heng Y, Yang Z, Zhang H, Kielczewska D, Mijakowski P, Connolly K, Dziomba M, Wilkes RJ. Search for differences in oscillation parameters for atmospheric neutrinos and antineutrinos at Super-Kamiokande. PHYSICAL REVIEW LETTERS 2011; 107:241801. [PMID: 22242990 DOI: 10.1103/physrevlett.107.241801] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/09/2011] [Indexed: 05/31/2023]
Abstract
We present a search for differences in the oscillations of antineutrinos and neutrinos in the Super-Kamiokande-I, -II, and -III atmospheric neutrino sample. Under a two-flavor disappearance model with separate mixing parameters between neutrinos and antineutrinos, we find no evidence for a difference in oscillation parameters. Best-fit antineutrino mixing is found to be at (Δm2,sin2 2θ)=(2.0×10(-3) eV2, 1.0) and is consistent with the overall Super-K measurement.
Collapse
|
52
|
Takada H, Kon S, Oyama Y. P4.43 Therapeutic effect of metformin against insulin resistance in myotonic dystrophy type 1. Neuromuscul Disord 2011. [DOI: 10.1016/j.nmd.2011.06.1008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
53
|
Abe K, Abgrall N, Ajima Y, Aihara H, Albert JB, Andreopoulos C, Andrieu B, Aoki S, Araoka O, Argyriades J, Ariga A, Ariga T, Assylbekov S, Autiero D, Badertscher A, Barbi M, Barker GJ, Barr G, Bass M, Bay F, Bentham S, Berardi V, Berger BE, Bertram I, Besnier M, Beucher J, Beznosko D, Bhadra S, Blaszczyk FDMM, Blondel A, Bojechko C, Bouchez J, Boyd SB, Bravar A, Bronner C, Brook-Roberge DG, Buchanan N, Budd H, Calvet D, Cartwright SL, Carver A, Castillo R, Catanesi MG, Cazes A, Cervera A, Chavez C, Choi S, Christodoulou G, Coleman J, Coleman W, Collazuol G, Connolly K, Curioni A, Dabrowska A, Danko I, Das R, Davies GS, Davis S, Day M, De Rosa G, de André JPAM, de Perio P, Delbart A, Densham C, Di Lodovico F, Di Luise S, Dinh Tran P, Dobson J, Dore U, Drapier O, Dufour F, Dumarchez J, Dytman S, Dziewiecki M, Dziomba M, Emery S, Ereditato A, Escudero L, Esposito LS, Fechner M, Ferrero A, Finch AJ, Frank E, Fujii Y, Fukuda Y, Galymov V, Gannaway FC, Gaudin A, Gendotti A, George MA, Giffin S, Giganti C, Gilje K, Golan T, Goldhaber M, Gomez-Cadenas JJ, Gonin M, Grant N, Grant A, Gumplinger P, Guzowski P, Haesler A, Haigh MD, Hamano K, Hansen C, Hansen D, Hara T, Harrison PF, Hartfiel B, Hartz M, Haruyama T, Hasegawa T, Hastings NC, Hastings S, Hatzikoutelis A, Hayashi K, Hayato Y, Hearty C, Helmer RL, Henderson R, Higashi N, Hignight J, Hirose E, Holeczek J, Horikawa S, Hyndman A, Ichikawa AK, Ieki K, Ieva M, Iida M, Ikeda M, Ilic J, Imber J, Ishida T, Ishihara C, Ishii T, Ives SJ, Iwasaki M, Iyogi K, Izmaylov A, Jamieson B, Johnson RA, Joo KK, Jover-Manas GV, Jung CK, Kaji H, Kajita T, Kakuno H, Kameda J, Kaneyuki K, Karlen D, Kasami K, Kato I, Kearns E, Khabibullin M, Khanam F, Khotjantsev A, Kielczewska D, Kikawa T, Kim J, Kim JY, Kim SB, Kimura N, Kirby B, Kisiel J, Kitching P, Kobayashi T, Kogan G, Koike S, Konaka A, Kormos LL, Korzenev A, Koseki K, Koshio Y, Kouzuma Y, Kowalik K, Kravtsov V, Kreslo I, Kropp W, Kubo H, Kudenko Y, Kulkarni N, Kurjata R, Kutter T, Lagoda J, Laihem K, Laveder M, Lee KP, Le PT, Levy JM, Licciardi C, Lim IT, Lindner T, Litchfield RP, Litos M, Longhin A, Lopez GD, Loverre PF, Ludovici L, Lux T, Macaire M, Mahn K, Makida Y, Malek M, Manly S, Marchionni A, Marino AD, Marteau J, Martin JF, Maruyama T, Maryon T, Marzec J, Masliah P, Mathie EL, Matsumura C, Matsuoka K, Matveev V, Mavrokoridis K, Mazzucato E, McCauley N, McFarland KS, McGrew C, McLachlan T, Messina M, Metcalf W, Metelko C, Mezzetto M, Mijakowski P, Miller CA, Minamino A, Mineev O, Mine S, Missert AD, Mituka G, Miura M, Mizouchi K, Monfregola L, Moreau F, Morgan B, Moriyama S, Muir A, Murakami A, Murdoch M, Murphy S, Myslik J, Nakadaira T, Nakahata M, Nakai T, Nakajima K, Nakamoto T, Nakamura K, Nakayama S, Nakaya T, Naples D, Navin ML, Nelson B, Nicholls TC, Nishikawa K, Nishino H, Nowak JA, Noy M, Obayashi Y, Ogitsu T, Ohhata H, Okamura T, Okumura K, Okusawa T, Oser SM, Otani M, Owen RA, Oyama Y, Ozaki T, Pac MY, Palladino V, Paolone V, Paul P, Payne D, Pearce GF, Perkin JD, Pettinacci V, Pierre F, Poplawska E, Popov B, Posiadala M, Poutissou JM, Poutissou R, Przewlocki P, Qian W, Raaf JL, Radicioni E, Ratoff PN, Raufer TM, Ravonel M, Raymond M, Retiere F, Robert A, Rodrigues PA, Rondio E, Roney JM, Rossi B, Roth S, Rubbia A, Ruterbories D, Sabouri S, Sacco R, Sakashita K, Sánchez F, Sarrat A, Sasaki K, Scholberg K, Schwehr J, Scott M, Scully DI, Seiya Y, Sekiguchi T, Sekiya H, Shibata M, Shimizu Y, Shiozawa M, Short S, Siyad M, Smith RJ, Smy M, Sobczyk JT, Sobel H, Sorel M, Stahl A, Stamoulis P, Steinmann J, Still B, Stone J, Strabel C, Sulak LR, Sulej R, Sutcliffe P, Suzuki A, Suzuki K, Suzuki S, Suzuki SY, Suzuki Y, Suzuki Y, Szeglowski T, Szeptycka M, Tacik R, Tada M, Takahashi S, Takeda A, Takenaga Y, Takeuchi Y, Tanaka K, Tanaka HA, Tanaka M, Tanaka MM, Tanimoto N, Tashiro K, Taylor I, Terashima A, Terhorst D, Terri R, Thompson LF, Thorley A, Toki W, Tomaru T, Totsuka Y, Touramanis C, Tsukamoto T, Tzanov M, Uchida Y, Ueno K, Vacheret A, Vagins M, Vasseur G, Wachala T, Walding JJ, Waldron AV, Walter CW, Wanderer PJ, Wang J, Ward MA, Ward GP, Wark D, Wascko MO, Weber A, Wendell R, West N, Whitehead LH, Wikström G, Wilkes RJ, Wilking MJ, Wilson JR, Wilson RJ, Wongjirad T, Yamada S, Yamada Y, Yamamoto A, Yamamoto K, Yamanoi Y, Yamaoka H, Yanagisawa C, Yano T, Yen S, Yershov N, Yokoyama M, Zalewska A, Zalipska J, Zambelli L, Zaremba K, Ziembicki M, Zimmerman ED, Zito M, Żmuda J. Indication of electron neutrino appearance from an accelerator-produced off-axis muon neutrino beam. PHYSICAL REVIEW LETTERS 2011; 107:041801. [PMID: 21866992 DOI: 10.1103/physrevlett.107.041801] [Citation(s) in RCA: 65] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/13/2011] [Indexed: 05/31/2023]
Abstract
The T2K experiment observes indications of ν(μ) → ν(e) appearance in data accumulated with 1.43×10(20) protons on target. Six events pass all selection criteria at the far detector. In a three-flavor neutrino oscillation scenario with |Δm(23)(2)| = 2.4×10(-3) eV(2), sin(2)2θ(23) = 1 and sin(2)2θ(13) = 0, the expected number of such events is 1.5±0.3(syst). Under this hypothesis, the probability to observe six or more candidate events is 7×10(-3), equivalent to 2.5σ significance. At 90% C.L., the data are consistent with 0.03(0.04) < sin(2)2θ(13) < 0.28(0.34) for δ(CP) = 0 and a normal (inverted) hierarchy.
Collapse
|
54
|
Maeda K, Takano J, Ikeda Y, Fujita T, Oyama Y, Nozawa K, Kumagai Y, Sugiyama Y. Nonlinear Pharmacokinetics of Oral Quinidine and Verapamil in Healthy Subjects: A Clinical Microdosing Study. Clin Pharmacol Ther 2011; 90:263-70. [DOI: 10.1038/clpt.2011.108] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
55
|
Takada H, Kon S, Oyama Y, Gotoh T. P2.30 Oral fat loading study – does specific hyperlipemia exist in myotonic dystrophy type 1? Neuromuscul Disord 2010. [DOI: 10.1016/j.nmd.2010.07.102] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
56
|
Takada H, Kon S, Oyama Y, Gotoh T. FP45-TH-02 Hypothesis for the stages of glucose intolerance in myotonic dystrophy: evaluation by glucose tolerance test. J Neurol Sci 2009. [DOI: 10.1016/s0022-510x(09)70507-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
57
|
Nishino H, Clark S, Abe K, Hayato Y, Iida T, Ikeda M, Kameda J, Kobayashi K, Koshio Y, Miura M, Moriyama S, Nakahata M, Nakayama S, Obayashi Y, Ogawa H, Sekiya H, Shiozawa M, Suzuki Y, Takeda A, Takenaga Y, Takeuchi Y, Ueno K, Ueshima K, Watanabe H, Yamada S, Hazama S, Higuchi I, Ishihara C, Kajita T, Kaneyuki K, Mitsuka G, Okumura K, Tanimoto N, Vagins MR, Dufour F, Kearns E, Litos M, Raaf JL, Stone JL, Sulak LR, Wang W, Goldhaber M, Dazeley S, Svoboda R, Bays K, Casper D, Cravens JP, Kropp WR, Mine S, Regis C, Smy MB, Sobel HW, Ganezer KS, Hill J, Keig WE, Jang JS, Kim JY, Lim IT, Fechner M, Scholberg K, Walter CW, Wendell R, Tasaka S, Learned JG, Matsuno S, Watanabe Y, Hasegawa T, Ishida T, Ishii T, Kobayashi T, Nakadaira T, Nakamura K, Nishikawa K, Oyama Y, Sakashita K, Sekiguchi T, Tsukamoto T, Suzuki AT, Minamino A, Nakaya T, Yokoyama M, Fukuda Y, Itow Y, Tanaka T, Jung CK, Lopez G, McGrew C, Terri R, Yanagisawa C, Tamura N, Idehara Y, Sakuda M, Kuno Y, Yoshida M, Kim SB, Yang BS, Ishizuka T, Okazawa H, Choi Y, Seo HK, Furuse Y, Nishijima K, Yokosawa Y, Koshiba M, Totsuka Y, Chen S, Heng Y, Yang Z, Zhang H, Kielczewska D, Thrane E, Wilkes RJ. Search for proton decay via p-->e+pi0 and p-->micro+pi0 in a large water Cherenkov detector. PHYSICAL REVIEW LETTERS 2009; 102:141801. [PMID: 19392425 DOI: 10.1103/physrevlett.102.141801] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/09/2009] [Indexed: 05/27/2023]
Abstract
We have searched for proton decays via p-->e;{+}pi;{0} and p-->micro;{+}pi;{0} using data from a 91.7 kt.yr exposure of Super-Kamiokande-I and a 49.2 kt.yr exposure of Super-Kamiokande-II. No candidate events were observed with expected backgrounds induced by atmospheric neutrinos of 0.3 events for each decay mode. From these results, we set lower limits on the partial lifetime of 8.2 x 10;{33} and 6.6 x 10;{33} years at 90% confidence level for p-->e;{+}pi;{0} and p-->micro;{+}pi;{0} modes, respectively.
Collapse
|
58
|
Takada H, Kon S, Oyama Y. WITHDRAWN: P.P.2 04 Chronological observation of glucose intolerance in myotonic dystrophy. Neuromuscul Disord 2009:S0960-8966(06)00256-2. [PMID: 19324549 DOI: 10.1016/j.nmd.2006.05.098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
Collapse
|
59
|
Katoh T, Kinoshita S, Tsujimura Y, Sasaki Y, Oyama Y. Tachycardia-dependent right bundle-branch block with supernormal conduction. Clin Cardiol 2009; 23:59-62. [PMID: 10680033 PMCID: PMC6654873 DOI: 10.1002/clc.4960230121] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
This paper reports the case of a 76-year-old man in whom atrial flutter with varying atrioventricular block and intermittent right bundle-branch block was found. This is the first report on tachycardia-dependent right bundle-branch block associated with supernormal conduction in a case of atrial flutter. When an impulse is conducted to the ventricles beyond 0.72 s after a QRS complex of right bundle-branch block configuration, the impulse falls after the abnormally long effective refractor period of the right bundle branch and passes through the right bundle branch. When the conducted impulse occurs within 0.72 s after a QRS complex of right bundle-branch block configuration, the impulse usually falls in the refractory period and is blocked in the right bundle branch; however, only when the impulse occurs 0.48 or 0.49 s after that does it fall in the supernormal period and passes through the right bundle branch. The findings in the present report strengthen our previous suggestion that the presence of supernormal conduction plays an important role in the initiation of reentrant ventricular tachycardia.
Collapse
|
60
|
Ashizuka M, Oyama Y, Kubota Y, Ikari T, Oka S, Inoue Y, Shirasuna K. P.362 Mucinous adenocarcinoma of the sublingual gland. J Craniomaxillofac Surg 2008. [DOI: 10.1016/s1010-5182(08)72150-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
61
|
Abe K, Hayato Y, Iida T, Ikeda M, Kameda J, Koshio Y, Minamino A, Miura M, Moriyama S, Nakahata M, Nakayama S, Obayashi Y, Ogawa H, Sekiya H, Shiozawa M, Suzuki Y, Takeda A, Takeuchi Y, Ueshima K, Watanabe H, Yamada S, Higuchi I, Ishihara C, Kajita T, Kaneyuki K, Mitsuka G, Nishino H, Okumura K, Saji C, Takenaga Y, Clark S, Desai S, Dufour F, Kearns E, Likhoded S, Litos M, Raaf JL, Stone JL, Sulak LR, Wang W, Goldhaber M, Casper D, Cravens JP, Dunmore J, Kropp WR, Liu DW, Mine S, Regis C, Smy MB, Sobel HW, Vagins MR, Ganezer KS, Hartfield B, Hill J, Keig WE, Jang JS, Jeong IS, Kim JY, Lim IT, Scholberg K, Fechner M, Tanimoto N, Walter CW, Wendell R, Tasaka S, Guillian G, Learned JG, Matsuno S, Messier MD, Hasegawa T, Ishida T, Ishii T, Kobayashi T, Nakadaira T, Nakamura K, Nishikawa K, Oyama Y, Totsuka Y, Suzuki AT, Nakaya T, Tanaka H, Yokoyama M, Haines TJ, Dazeley S, Svoboda R, Habig A, Fukuda Y, Sato T, Itow Y, Koike T, Tanaka T, Jung CK, Kato T, Kobayashi K, McGrew C, Sarrat A, Terri R, Yanagisawa C, Tamura N, Idehara Y, Sakuda M, Sugihara M, Kuno Y, Yoshida M, Kim SB, Yang BS, Ishizuka T, Okazawa H, Choi Y, Seo HK, Gando Y, Inoue K, Furuse Y, Ishii H, Nishijima K, Watanabe Y, Koshiba M, Chen S, Deng Z, Liu Y, Kielczewska D, Berns H, Shiraishi KK, Thrane E, Wilkes RJ. Search for matter-dependent atmospheric neutrino oscillations in Super-Kamiokande. Int J Clin Exp Med 2008. [DOI: 10.1103/physrevd.77.052001] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
62
|
Matsuoka T, Okuma T, Yamamoto A, Oyama Y, Toyoshima M, Nakamura K, Inoue Y. Abstract No. 105: Influences of Radiofrequency Ablation for Lung Tumors on Pulmonary Function. J Vasc Interv Radiol 2008. [DOI: 10.1016/j.jvir.2007.12.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
63
|
Oyama Y, Sufit R, Loh Y, Statkute L, Yaung K, Quigley K, Gonda E, Spahovic D, Bronesky D, Burt RK. Nonmyeloablative autologous hematopoietic stem celltransplantation for refractory CIDP. Neurology 2007; 69:1802-3. [PMID: 17967996 DOI: 10.1212/01.wnl.0000277266.53449.8b] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
64
|
Statkute L, Oyama Y, Barr WG, Sufit R, Ho S, Verda L, Loh Y, Yaung K, Quigley K, Burt RK. Autologous non-myeloablative haematopoietic stem cell transplantation for refractory systemic vasculitis. Ann Rheum Dis 2007; 67:991-7. [PMID: 17947303 DOI: 10.1136/ard.2007.070227] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
OBJECTIVE For patients with systemic vasculitis (SV) refractory to conventional therapy, new treatment strategies aimed at aggressive induction of remission and relapse prevention are being sought. We herein report our single-centre experience in treating four patients with refractory SV employing non-myeloablative autologous haematopoietic stem cell transplantation (HSCT). METHODS Four patients with refractory SV (two with neurovascular Behcet disease, one with neurovascular Sjögren syndrome, and one with Wegener granulomatosis) were involved in an Institutional Review Board (IRB) and US Food and Drug Administration (FDA) approved phase I clinical trial of high dose chemotherapy and autologous HSCT. Peripheral blood stem cells were mobilised with cyclophosphamide (Cy) and granulocyte-colony stimulating factor (G-CSF). Conditioning regimen consisted of Cy 200 mg/kg and rabbit anti-thymocyte globulin 5.5 mg/kg intravenously (iv). RESULTS All four patients tolerated HSCT well without transplant related mortality or any significant toxicity. At median follow-up of 28 (range 22-36) months all patients were alive. Three patients (one with Behcet disease, one with Sjögren syndrome, and one with Wegener granulomatosis) entered a sustained remission at 6, 6 and 24 months, respectively, after transplant. They had significant decrease in disease activity and disease or treatment related damage, as measured by the Birmingham Vasculitis Activity Score and Vasculitis Damage Index, respectively. All three patients who achieved remission discontinued immunosuppressive therapy at the time of transplant and have not required treatment since. One patient with Behcet disease and positive for human leukocyte antigen (HLA)-B51 has not improved after HSCT. CONCLUSION We suggest non-myeloablative autologous HSCT is an alternative therapy for select patients with SV refractory to conventional immunosuppressive therapies.
Collapse
|
65
|
Oyama Y, Barr WG, Statkute L, Corbridge T, Gonda EA, Jovanovic B, Testori A, Burt RK. Autologous non-myeloablative hematopoietic stem cell transplantation in patients with systemic sclerosis. Bone Marrow Transplant 2007; 40:549-55. [PMID: 17646844 DOI: 10.1038/sj.bmt.1705782] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Autologous hematopoietic stem cell transplantation (HSCT) utilizing a myeloablative regimen containing total body irradiation has been performed in patients with systemic sclerosis (SSc), but with substantial toxicity. We, therefore, conducted a phase I non-myeloablative autologous HSCT study in 10 patients with SSc and poor prognostic features. PBSC were mobilized with CY and G-CSF. The PBSC graft was cryopreserved without manipulation and re-infused after the patient was treated with a non-myeloablative conditioning regimen of 200 mg/kg CY and 7.5 mg/kg rabbit antithymocyte globulin. There was a statistically significant improvement of modified Rodnan skin score whereas cardiac (ejection fraction, pulmonary arterial pressure), pulmonary function (DLCO) and renal function (creatinine) remained stable without significant change. One patient with advanced disease died 2 years after the transplant from progressive disease. After median follow-up of 25.5 months, the overall and progression-free survival rates are 90 and 70% respectively. Autologous HSCT utilizing a non-myeloablative conditioning regimen appears to result in improved skin flexibility similar to a myeloablative TBI containing regimen, but without the toxicity and risks associated with TBI.
Collapse
|
66
|
Oyama Y, Talamonti M, Mulcahy M, Gonda E, Burt RK, Vahanian NN, Bell R, Tennant L, Ramsey WJ, Adrian T, Link C. A phase I/II study of an antitumor vaccination using α (1,3) galactosyltransferase expressing allogeneic tumor cells in pancreatic cancer. J Clin Oncol 2007. [DOI: 10.1200/jco.2007.25.18_suppl.13512] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
13512 Background: Prognosis of pancreatic cancer remains poor despite surgical resection. In a phase I trial, we examined the safety and feasibility of antitumor vaccination in Pts with surgically resected pancreatic cancer with two irradiated genetically altered human pancreatic cancer cell lines engineered to express xenotransplantation antigens by retroviral transfer of the murine a(1,3) galactosyltrasferase gene {HyperAcute Pancreatic Cancer Vaccine (HAPa)}. Methods: Pts had undergone complete surgical resection for stage IA to IIB pancreatic adenocarcinoma, ECOG PS≤2, no immunosuppressive drug use and an adequate organ function were eligible. Various adjuvant treatments were allowed prior to the start of HAPa according to the institutional preferences (5FU/radiation, cisplatin/gemicitabine followed by 5FU/radiation, 5FU/radiation followed by gemicitabine or gemicitabine/capecitabine/bevasizumab/radiation). Six Pts were scheduled to receive 12 every two week-intradermal injections (initial priming dose followed by 11 boost doses). The first cohort (Pts 1–3) was to receive at lower doses (2 × 108 cells priming and 1 x 108 cells boost). The second cohort (Pts 4–6) was to receive at higher doses (5 x 10^8 cells priming and 3 x 10^8 cells boost). Toxicity was assessed using the CTC v3.0. Results: To date, 6 Pts, 3 males, 3 females, median age 59 (range 50–66) were treated. Two Pts completed all 12 injections. Others received 9, 6, 6 and 4 injections, respectively. To date no serious adverse events can be attributed to the vaccine. Adverse events (≤CTC grade 2) attributable to the vaccine include injection site pain/discomfort and local skin reaction in all Pts. Other adverse events (≤grade 2) include hyperkalemia, fever and increased LDH levels in one Pt. One Pt with non-malignant hepatic lesions at the time of initial surgery was removed from the study after confirmation of metastatic disease in the liver. At this point the median 6.5 (range 9–4) months in the study all remaining (5/6) patients have no evidence of recurrent disease. Conclusions: Preliminary data indicate that antitumor vaccination with genetically altered allogeneic human pancreatic cancer cells expressing a(1, 3) galactosyltrasferase is safe and feasible [Table: see text]
Collapse
|
67
|
Loh Y, Oyama Y, Statkute L, Traynor A, Satkus J, Quigley K, Yaung K, Barr W, Bucha J, Gheorghiade M, Burt RK. Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission. Bone Marrow Transplant 2007; 40:47-53. [PMID: 17483845 DOI: 10.1038/sj.bmt.1705698] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Patients with cardiac dysfunction may be at increased risk of cardiac toxicity when undergoing hematopoietic stem cell transplantation (HSCT), which may preclude them from receiving this therapy. Cardiac dysfunction is, however, common in systemic lupus erythematosus (SLE) patients. While autologous HSCT (auto-HSCT) has been performed increasingly for SLE, its impact on cardiac function has not previously been evaluated. We, therefore, performed a retrospective analysis of SLE patients who had undergone auto-HSCT in our center to determine the prevalence of significant cardiac involvement, and the impact of transplantation on this. The records of 55 patients were reviewed, of which 13 were found to have abnormal cardiac findings on pre-transplant two-dimensional echocardiography or multi-gated acquisition scan: impaired left ventricular ejection fraction (LVEF) (n = 6), pulmonary hypertension (n = 5), mitral valve dysfunction (n = 3) and large pericardial effusion (n = 1). At a median follow-up of 24 months (8-105 months), there were no transplant-related or cardiac deaths. With transplant-induced disease remission, all patients with impaired LVEF remained stable or improved; while three with symptomatic mitral valve disease similarly improved. Elevated pulmonary pressures paralleled activity of underlying lupus. These data suggest that auto-HSCT is feasible in selected patients with lupus-related cardiac dysfunction, and with control of disease activity, may improve.
Collapse
|
68
|
Loh Y, Oyama Y, Statkute L, Verda L, Quigley K, Yaung K, Barr W, Jovanovic B, Burt RK. Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: graft-versus-autoimmunity without graft-versus-host disease? Bone Marrow Transplant 2007; 39:435-7. [PMID: 17310133 DOI: 10.1038/sj.bmt.1705611] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
|
69
|
Statkute L, Verda L, Oyama Y, Traynor A, Villa M, Shook T, Clifton R, Jovanovic B, Satkus J, Loh Y, Quigley K, Yaung K, Gonda E, Krosnjar N, Spahovic D, Burt RK. Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39:317-29. [PMID: 17277794 DOI: 10.1038/sj.bmt.1705579] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Peripheral blood stem cells (PBSC) were mobilized in 130 patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation using cyclophosphamide 2 g/m(2) and either granulocyte colony-stimulating factor (G-CSF) 5 mcg/kg/day (for systemic lupus erythematosus (SLE) and secondary progressive multiple sclerosis, SPMS) or G-CSF 10 mcg/kg/day (for relapsing remitting multiple sclerosis (RRMS), Crohn's disease (CD), systemic sclerosis (SSc), and other immune-mediated disorders). Mobilization-related mortality was 0.8% (one of 130) secondary to infection. Circulating peripheral blood (PB) CD34(+) cells/microl differed significantly by disease. Collected CD34(+) cells/kg/apheresis and overall collection efficiency was significantly better using Spectra apheresis device compared to the Fenwall CS3000 instrument. Patients with SLE and RRMS achieved the lowest and the highest CD34(+) cell yields, respectively. Ex vivo CD34(+) cell selection employing Isolex 300iv2.5 apparatus was significantly more efficient compared to CEPRATE CS device. Circulating PB CD34(+) cells/microl correlated positively with initial CD34(+) cells/kg/apheresis and enriched product CD34(+) cells/kg. Mean WBC and platelet engraftment (ANC>0.5 x 10(9)/l and platelet count >20 x 10(9)/l) occurred on days 9 and 11, respectively. Infused CD34(+) cell/kg dose showed significant direct correlation with faster white blood cell (WBC) and platelet engraftment. When adjusted for CD34(+) cell/kg dose, patients treated with a myeloablative regimen had significantly slower WBC and platelet recovery compared to non-myeloablative regimens.
Collapse
|
70
|
Abe K, Hayato Y, Iida T, Ishihara K, Kameda J, Koshio Y, Minamino A, Mitsuda C, Miura M, Moriyama S, Nakahata M, Obayashi Y, Ogawa H, Shiozawa M, Suzuki Y, Takeda A, Takeuchi Y, Ueshima K, Higuchi I, Ishihara C, Ishitsuka M, Kajita T, Kaneyuki K, Mitsuka G, Nakayama S, Nishino H, Okumura K, Saji C, Takenaga Y, Totsuka Y, Clark S, Desai S, Dufour F, Kearns E, Likhoded S, Litos M, Raaf JL, Stone JL, Sulak LR, Wang W, Goldhaber M, Casper D, Cravens JP, Kropp WR, Liu DW, Mine S, Regis C, Smy MB, Sobel HW, Vagins MR, Ganezer KS, Hill JE, Keig WE, Jang JS, Kim JY, Lim IT, Scholberg K, Tanimoto N, Walter CW, Wendell R, Ellsworth RW, Tasaka S, Guillian E, Learned JG, Matsuno S, Messier MD, Ichikawa AK, Ishida T, Ishii T, Iwashita T, Kobayashi T, Nakadaira T, Nakamura K, Nitta K, Oyama Y, Suzuki AT, Hasegawa M, Kato I, Maesaka H, Nakaya T, Nishikawa K, Sasaki T, Sato H, Yamamoto S, Yokoyama M, Haines TJ, Dazeley S, Hatakeyama S, Svoboda R, Sullivan GW, Habig A, Gran R, Fukuda Y, Sato T, Itow Y, Koike T, Jung CK, Kato T, Kobayashi K, Malek M, McGrew C, Sarrat A, Terri R, Yanagisawa C, Tamura N, Sakuda M, Sugihara M, Kuno Y, Yoshida M, Kim SB, Yoo J, Ishizuka T, Okazawa H, Choi Y, Seo HK, Gando Y, Hasegawa T, Inoue K, Ishii H, Nishijima K, Ishino H, Watanabe Y, Koshiba M, Kielczewska D, Zalipska J, Berns HG, Shiraishi KK, Washburn K, Wilkes RJ. Measurement of atmospheric neutrino flux consistent with tau neutrino appearance. PHYSICAL REVIEW LETTERS 2006; 97:171801. [PMID: 17155460 DOI: 10.1103/physrevlett.97.171801] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/25/2006] [Indexed: 05/12/2023]
Abstract
A search for the appearance of tau neutrinos from nu(mu) <--> nu(tau) oscillations in the atmospheric neutrinos has been performed using 1489.2 days of atmospheric neutrino data from the Super-Kamiokande-I experiment. A best fit tau neutrino appearance signal of 138+/-48(stat)-32(+15)(syst) events is obtained with an expectation of 78+/-26(syst). The hypothesis of no tau neutrino appearance is disfavored by 2.4 sigma.
Collapse
|
71
|
Verda L, Luo K, Kim DA, Bronesky D, Kohm AP, Miller SD, Statkute L, Oyama Y, Burt RK. Effect of hematopoietic growth factors on severity of experimental autoimmune encephalomyelitis. Bone Marrow Transplant 2006; 38:453-60. [PMID: 16951693 DOI: 10.1038/sj.bmt.1705473] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
We have investigated the influence of different hematopoietic growth factors, including granulocyte colony-stimulating factor (G-CSF), stem cell factor (SCF), Flt-3 ligand (Flt-3L) and thrombopoietin (TPO), on the course of relapsing experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Disease course and central nervous system histology were evaluated in all groups. When given after immunization but before either disease onset or during remission, Flt-3L, SCF and G-CSF exacerbated disease severity whereas TPO had no effect compared to non-cytokine-treated controls. When compared to controls, TPO did not exacerbate disease. We conclude that autoimmune disease severity may be affected by hematopoietic growth factors currently being employed in hematopoietic stem cell transplantation of patients with autoimmune disease. The mechanism of their effects remains unknown: it may be related to both T helper (Th) 1/Th2 skewing and/or homing of inflammatory cells to the disease-affected organ.
Collapse
|
72
|
Sato K, Saito R, Oyama Y, Jiang J, Cançado L, Pimenta M, Jorio A, Samsonidze G, Dresselhaus G, Dresselhaus M. D-band Raman intensity of graphitic materials as a function of laser energy and crystallite size. Chem Phys Lett 2006. [DOI: 10.1016/j.cplett.2006.05.107] [Citation(s) in RCA: 165] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
73
|
Yamamoto S, Zalipska J, Aliu E, Andringa S, Aoki S, Argyriades J, Asakura K, Ashie R, Berghaus F, Berns H, Bhang H, Blondel A, Borghi S, Bouchez J, Burguet-Castell J, Casper D, Catala J, Cavata C, Cervera A, Chen SM, Cho KO, Choi JH, Dore U, Espinal X, Fechner M, Fernandez E, Fukuda Y, Gomez-Cadenas J, Gran R, Hara T, Hasegawa M, Hasegawa T, Hayashi K, Hayato Y, Helmer RL, Hiraide K, Hosaka J, Ichikawa AK, Iinuma M, Ikeda A, Inagaki T, Ishida T, Ishihara K, Ishii T, Ishitsuka M, Itow Y, Iwashita T, Jang HI, Jeon EJ, Jeong IS, Joo KK, Jover G, Jung CK, Kajita T, Kameda J, Kaneyuki K, Kato I, Kearns E, Kerr D, Kim CO, Khabibullin M, Khotjantsev A, Kielczewska D, Kim JY, Kim SB, Kitching P, Kobayashi K, Kobayashi T, Konaka A, Koshio Y, Kropp W, Kubota J, Kudenko Y, Kuno Y, Kurimoto Y, Kutter T, Learned J, Likhoded S, Lim IT, Loverre PF, Ludovici L, Maesaka H, Mallet J, Mariani C, Matsuno S, Matveev V, McConnel K, McGrew C, Mikheyev S, Minamino A, Mine S, Mineev O, Mitsuda C, Miura M, Moriguchi Y, Morita T, Moriyama S, Nakadaira T, Nakahata M, Nakamura K, Nakano I, Nakaya T, Nakayama S, Namba T, Nambu R, Nawang S, Nishikawa K, Nitta K, Nova F, Novella P, Obayashi Y, Okada A, Okumura K, Oser SM, Oyama Y, Pac MY, Pierre F, Rodriguez A, Saji C, Sakuda M, Sanchez F, Sarrat A, Sasaki T, Sato H, Scholberg K, Schroeter R, Sekiguchi M, Shiozawa M, Shiraishi K, Sitjes G, Smy M, Sobel H, Sorel M, Stone J, Sulak L, Suzuki A, Suzuki Y, Takahashi T, Takenaga Y, Takeuchi Y, Taki K, Takubo Y, Tamura N, Tanaka M, Terri R, T'jampens S, Tornero-Lopez A, Totsuka Y, Ueda S, Vagins M, Whitehead L, Walter CW, Wang W, Wilkes RJ, Yamada S, Yanagisawa C, Yershov N, Yokoyama H, Yokoyama M, Yoo J, Yoshida M. Improved search for nu(mu) --> nu(e) oscillation in a long-baseline accelerator experiment. PHYSICAL REVIEW LETTERS 2006; 96:181801. [PMID: 16712358 DOI: 10.1103/physrevlett.96.181801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/02/2006] [Indexed: 05/09/2023]
Abstract
We performed an improved search for nu(mu) --> nu(e) oscillation with the KEK to Kamioka (K2K) long-baseline neutrino oscillation experiment, using the full data sample of 9.2 x 10(19) protons on target. No evidence for a nu(e) appearance signal was found, and we set bounds on the nu(mu) --> nu(e) oscillation parameters. At Deltam(2)=2.8 x 10(-3) eV(2), the best-fit value of the K2Knu(mu) disappearance analysis, we set an upper limit of sin(2)2theta(mue) < 0.13 at a 90% confidence level.
Collapse
|
74
|
Statkute L, Verda L, Oyama Y, Villa M, Shook T, Clifton R, Krosnjar N, Quigley K, Yaung K, Weppner C, Burt R. Mobilization, harvesting, and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing non-myeloablative autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006. [DOI: 10.1016/j.bbmt.2005.11.315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
75
|
Burt R, Oyama Y, Statkute L, Quigley K, Weppner C, Krosnjar N, Verda L. Non-myeloablative autologous hematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis. Biol Blood Marrow Transplant 2006. [DOI: 10.1016/j.bbmt.2005.11.276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|